Natural Alternatives International Welcomes New CarnoSyn® Brands Business Development Manager to Support Market Expansion
CARLSBAD, Calif., November 7, 2018 – Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII) is proud to announce and welcome Steve Polzin as CarnoSyn® Brands General Wellness Business Development Manager. Steve will be responsible for sales team leadership and driving new business growth and revenue in support of the expansion of SR CarnoSyn® beta-alanine into the everyday wellness and healthy aging markets.
Throughout his 30-year career, Steve has been recognized for his ability to grow a company’s business in all classes of trade, while collaboratively motivating a field sales team to exceed company goals. Steve’s prior experience includes sales management and directorial positions at such well-known companies as: GAIA Herbs, Mamma Chia, Renew Life, Ito En, High Ridge Brands, The Alacer Corporation, The Quigley Corporation, and Beiersdorf Inc.
“I’m excited to be part of the SR CarnoSyn® team. I’m looking forward to expanding SR CarnoSyn® into the health and wellness categories. I see the science behind SR CarnoSyn® and I believe consumers will embrace the myriad of health benefits it offers. I’m looking forward to taking it to new heights,” Polzin says.
“Steve’s strong history of building and maintaining relationships and his extensive experience in new business development will bode well for the goals set forth to expand SR CarnoSyn® into the everyday health and wellness categories,” stated Nicole Burbank, Vice President of CarnoSyn® Brands. “The entire team is looking forward to working with him, as we embark on this new journey to implement new growth strategies for our CarnoSyn® Brands.”
About CarnoSyn® Brands:
CarnoSyn® Brands feature two clinically studied, patented ingredients available exclusively from Natural Alternatives International, Inc.: CarnoSyn® instant release beta-alanine and SR CarnoSyn® sustained release beta-alanine. In the sports nutrition segment, both ingredients are well known to deliver benefits for athletic performance: increased strength, enhanced endurance, faster recovery, and greater mental focus.
SR CarnoSyn® is an advanced delivery form of CarnoSyn®, which delivers higher dosing levels of beta-alanine, and is proven to provide benefits for both brain health and muscle function and capacity. In 2017, SR CarnoSyn® was determined to be safe through independent scientific procedures, thus satisfying the technical element of the Generally Recognized as Safe (GRAS) determination. The GRAS affirmation allows NAI to broaden their product offerings beyond the sports nutrition space and focus on the dietary supplement and food and beverage industries, including medical and other fortified food products.
CarnoSyn® and SR CarnoSyn® are ultra-pure amino acids and banned substance free, backed by NAI’s commitment to the highest quality, potency, and manufacturing standards. For more information about CarnoSyn® and SR CarnoSyn®, please visit www.carnosyn.com and www.srcarnosyn.com.
NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. NAI’s comprehensive partnership approach offers a wide range of innovative nutritional products and services to our clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please visit www.nai-online.com.
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our future revenue profits and financial condition, our ability to maintain our patents, generate revenues from the commercialization of our patents and trademarks, secure compliance with our intellectual property rights, and develop, maintain or increase sales to new and existing customers, as well as future economic conditions and the impact of such conditions on our business. We wish to caution readers that these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI’s financial performance and the forward-looking statements contained herein are further qualified by other risks, including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K.
SOURCE: Natural Alternatives International, Inc.
Renee Michaelson, CarnoSyn® Marketing Manager, Natural Alternatives International, Inc., at 760-736-7700 or [email protected].